Crosswinds Holdings Inc. Stock Other OTC
Equities
CRSWF
CA2276962008
Biotechnology & Medical Research
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 27.36M |
---|---|---|---|---|---|
Net income 2021 | -4M | Net income 2022 | -2M | EV / Sales 2021 | - |
Net cash position 2021 | 2.23 | Net cash position 2022 | 0.02 | EV / Sales 2022 | - |
P/E ratio 2021 |
-17.8
x | P/E ratio 2022 |
-9.17
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 60.21% |
1st Jan change | Capi. | |
---|---|---|
+25.69% | 48.09B | |
+46.90% | 40.62B | |
-3.46% | 40.43B | |
-6.20% | 28.36B | |
+9.17% | 24.89B | |
-20.42% | 19.01B | |
+28.07% | 12.09B | |
+0.17% | 11.88B | |
-1.24% | 11.8B |